Home Tags JS212

Tag: JS212

AACR 2026: Emerging Antibody-Drug Conjugates for the Treatment of Solid Tumors...

AACR 2026: Emerging Antibody-Drug Conjugates for the Treatment of Solid Tumors (Part 1)

China’s Regulator Approves IND for JS212, a Bispecific ADC

The National Medical Products Administration (NMPA) of China, a part of  the National Medical Products Administration (NMPA) of China has approved the Investigational New...